We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
OMLYCLO
Australian Public Assessment Report
Device/Product Name
OMLYCLO
Active ingredients
Omalizumab
AusPAR Date
Published
Submission Number
PM-2023-04803-1-5
Submission Type
New biosimilar
Decision
Approved